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The macroscopic appearance of the major duodenal papilla 
influences bile duct cannulation: a prospective multicenter study 
by the Scandinavian Association for Digestive Endoscopy study 
group for ERCP 
 
Abstract 
 
Background and Aims: Certain appearances of the major duodenal papilla have been 
claimed to make cannulation more difficult during ERCP. This study uses a validated 
classification of the endoscopic appearance of the major duodenal papilla to determine if 
certain types of papilla predisposes to difficult cannulation. 
 
Methods: Patients, with a naïve papilla, scheduled for ERCP, were included. The papilla was 
classified into one of 4 papilla types before cannulation started. Time to successful bile duct 
cannulation, attempts and number of pancreatic duct passages were recorded. Difficult 
cannulation was defined as, after 5 minutes, 5 attempts, or 2 pancreatic guide-wire passages.  
 
Results: One thousand four hundred one patients were included from 9 different centers in 
the Nordic countries. The overall frequency of difficult cannulation was 42% (95% CI, 39%-
44%). Type 2, small papilla, (52%; 95% CI, 45%-59%) and Type 3 protruding or pendulous 
papilla (48%; 95% CI, 42%-53%) were more frequently difficult to cannulate compared with 
Type 1, regular papilla (36%; 95% CI, 33%-40%, both p<0.001). If an inexperienced 
endoscopist started cannulation, the frequency of failed cannulation increased from 1.9% to 
6.3% (p<0.0001), even though they were replaced by a senior endoscopist after 5 minutes.  
 
Conclusion: The endoscopic appearance of the major duodenal papilla influences bile duct 
cannulation. Small, Type 2, and protruding or pendulous Type 3 papillae are more frequently 
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difficult to cannulate. In addition, cannulation might even fail more frequently if a beginner 
starts cannulation. These findings have to be taken into consideration when performing 
studies regarding bile duct cannulation and in training future generations of endoscopists. 
 
 
Background 
How to best achieve a safe and effective bile duct cannulation during ERCP has always 
been, and still is, a much-debated issue1–3. Both technical- and patient-related aspects of 
cannulation and cannulation difficulties have previously been investigated4–6, but not if, 
and in what way, the endoscopic appearance of the major duodenal papilla may influence 
cannulation.  
All endoscopists who perform ERCP recognize the obvious differences in the 
macroscopic appearance of the major duodenal papilla7. This has led to a widespread 
conception among endoscopists that certain specified appearances of the papilla are more 
difficult to cannulate and therefore more prone to adverse events8–12. However, until now 
there has not been a structured investigation of what kind of influence the macroscopic 
appearance of the major duodenal papilla has on difficulties during bile duct cannulation. 
Before determining the association between the macroscopic appearance of the major 
duodenal papilla and cannulation difficulties some prerequisites have to be met. First, 
there has to be a clear definition of what is to be considered a difficult bile duct 
cannulation in order to make any evaluation of cannulation difficulties relevant and 
reproducible. There have been several different definitions used to investigate this 
matter13. However, since 2016, the European Society for Gastrointestinal Endoscopy 
(ESGE)14 recommends the use of the definition presented in the SADE group study15 
when investigating issues regarding difficult bile duct cannulation. This definition shows 
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a clear increase in adverse events when any of the criteria of: more than 5 minutes, 5 
attempts, or 2 pancreatic guidewire passages were met.  
Second, to make certain that different endoscopists are in agreement on the endoscopic 
appearance of the papilla, an interobserver-validated endoscopic classification has to be 
established. In our previously published paper, the first inter- and intraobserver-validated 
classification of the endoscopic appearance has been presented16 (Figure 1). 
With a validated classification and an accepted definition of difficult cannulation in place, 
we aim to determine the possible influence the endoscopic appearance of the major 
duodenal papilla has on the ability to perform bile duct cannulation during ERCP.  
Methods 
Patients from 9 different centers in the Nordic countries who, on clinical grounds, were 
scheduled for ERCP were prospectively included into the study. To be included, the 
patients had to be over 18 years old, have an intact, naïve, major duodenal papilla, and 
the desired duct to cannulate had to be the common bile duct. 
Exclusion criteria were a papilla hidden inside a large diverticulum or bulky tumors of 
the papilla that made classification impossible and also patients with surgically altered 
anatomy.  
Primary outcome measure was differences in the frequency of difficult cannulation 
distributed between the different papilla types. Difficult bile duct cannulation was defined 
using the 5-5-2 criterion, ie, after 5 minutes, 5 attempts or 2 pancreatic guidewire 
passages and when any of those limits is reached15.The endoscopic appearance of the 
major duodenal papilla was classified into 1 of the 4 distinctive papilla types: Regular 
(Type 1), small (Type 2), protruding or pendulous (Type 3) and creased or ridged (Type 
4) of our previously published classification16 (Figure 1). When, during the ERCP, the 
duodenoscope reached the papillary region in the duodenum, the endoscopist classified 
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the endoscopic appearance of the papilla into 1 of the 4 predefined papilla types. Two 
photographs of the papilla were captured with and without a cannulation catheter or 
sphincterotome alongside it for size reference. Thereafter, bile duct cannulation was 
initiated. Time was recorded from the first intentional touch of the papilla. The number of 
continuous contacts with the papilla, attempts, were recorded as well as all guidewire 
passages into the main pancreatic duct. When a guidewire or catheter was securely placed 
inside the common bile duct, determined by fluoroscopy, the stopwatch was terminated. 
The number of cannulation attempts and pancreatic guidewire passages was summarized. 
Data regarding the indication for the ERCP, patient demographics, methods used for 
cannulation, measures taken to avoid post ERCP pancreatitis (nonsteroidal anti-
inflammatory drugs [NSAIDs] and/or protective pancreatic endoprosthesis insertion), as 
well as post-ERCP adverse events occurring during the first 24 hours or before discharge 
were recorded. Adverse events were defined according to the consensus criteria17. No 
further follow-up of the severity of the adverse events were made.  
To determine the influence of endoscopists experience on difficulties during bile duct 
cannulation of the different papilla types, endoscopists of different levels of experience 
were allowed to start cannulation attempts. When an inexperienced endoscopist, ie, a 
“fellow,” started attempting bile duct cannulation and could not achieve deep bile duct 
cannulation within 5 minutes, a more senior colleague replaced the fellow and continued 
cannulation efforts. A fellow was defined as an endoscopist who had performed fewer 
than 200 career-long ERCPs18. Expert endoscopists were defined as having performed 
over 1000 ERCPs, and intermediate endoscopists were those who had performed 200 to 
1000 ERCPs during their career. Power calculations were not possible because the 
distribution of the different papilla types was previously unknown as was the overall 
frequency of difficult cannulation using the ESGE approved definition. The 5-5-2 (more 
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than 5 minutes, more than 5 attempts, 2 or more wire passages or contrast injections into 
the pancreatic duct) definition is based primarily on the work by the SADE study group 
of ERCP15, consisting of expert endoscopists. However, ESGE has recommended that 
this definition should be used in future studies investigating difficult cannulation. 
All statistical calculations were made with SPSS version 25. The Chi-square test or 
Fisher exact test were used for categorical data as appropriate, as well as odds ratio 
calculation. Mann-Whitney U-test was used for non-normally distributed continuous data.  
The study was approved by the ethical review board at the Karolinska Institutet, 
Stockholm (Dnr 2013/908-31/2). 
Results 
In total, 1401 patients were included in the study. Classification of the papilla into the 
predefined types was possible in 98% of the cases. In 2% (n=24) of the cases, the 
endoscopist was unable to select an appropriate papilla type and these 24 cases were 
excluded from further analyses. The endoscopist was asked to state a reason for inability 
to classify the papilla. In the majority (n=13) of cases a swollen papilla caused by 
inflammation, impacted stones or an unexpected finding of a tumor (exclusion criteria) 
was indicated as the causative factor. In 5 case reports, no explanation for inability to 
perform classification was given. It was in violation with the study protocol to classify 
the papillae in retrospect using the photos taken during the ERCP. In only 1 case did the 
endoscopist have problems in choosing between the defined papilla types. In the 
remaining 5 cases, classification was impossible due to inability to find the papilla 
because of extensive mucosal folds, large diverticulum (exclusion criteria), or narrow 
duodenal lumen hindering movement of the duodenoscope.  
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The distribution of the different papilla types is shown in Figure 2, with regular papilla, 
Type 1 being the most frequent (56%) followed by Type 3, protruding or pendulous 
papilla occurring in 23%. 
The mean age of the patients was 66 years (range 18-101 years), and 52% were female. 
The most common indications for ERCP were common bile duct stones 44%, followed 
by periampullary tumor19 (excluding tumors invading the papilla itself) and jaundice, see 
Table 1. No significant differences were seen between the different papilla types 
regarding age, sex, previous cholecystectomy rate, NSAID use, protective pancreatic 
stent or indications for ERCP, except for patients with creased or ridged papilla, Type 4. 
Compared with Type 1 papilla, patients with Type 4 papilla were, on average, younger 
(mean 59 years vs 66 years, p<0.0001) and had more frequently primary sclerosing 
cholangitis as an indication for ERCP (18.7% vs 5.7%, p<0.0001). In patients with Type 
3 papilla, periampullary diverticulum was not as frequent as in Type 1 papilla (6% vs 
13%, p=0.001). 
In most instances the cannulation attempts were started by an expert endoscopist (n=870, 
62%) and to a lesser extent by an endoscopist in the intermediate category (n=240, 17%). 
In 291 cases (21%), a fellow started the cannulation attempts. The level of endoscopist 
experience was evenly distributed among the different papilla types, with only minor, 
nonsignificant differences.  
The overall frequency of difficult cannulation regardless of papilla type was 42% (95% 
CI, 39%-44%). Among the different papilla types, difficult cannulation varied, as shown 
in Figure 3. Small papilla, Type 2 (52%; 95% CI, 45%-59%) and protruding or pendulous 
papilla, Type 3 (48%; 95% CI, 42%-53%) were significantly more often difficult to 
cannulate compared with regular, Type 1 papilla (36%; 95% CI, 33%-40%). There was, 
accordingly, an increased odds ratio (OR) for difficult cannulation for both small papilla 
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(OR, 1.89; 95% CI, 1.37-2.62) and protruding or pendulous Type 3 papilla (OR, 1.61; 
95% CI, 1.24-2.10) compared with regular, Type 1 papilla. Creased or ridged, Type 4 
papilla (43%; 95% CI, 34%-52%) did not show any significant difference from regular 
Type 1 papilla in the frequency of difficult cannulation.  
Cannulation difficulties were even more evident when endoscopists with different levels 
of experience attempted bile duct cannulation. Regardless of papilla type, bile duct 
cannulation was more often difficult when a fellow started (69%; 95% CI, 64%-74%) as 
well as when an endoscopist from the intermediate category started (49%; 95% CI, 42%-
55%) compared with when an expert started (30%; 95% CI, 27%-34%, both P values < 
.0001). The frequency of difficult cannulation for endoscopists with varying degrees of 
experience is shown in Table 2 
When only expert endoscopists performing bile duct cannulation on their own were 
analyzed, the result was similar as in the entire study population: a significantly higher 
frequency of difficult cannulation when cannulating small papilla, Type 2 (43%; 95% CI, 
34%-53%; p=0.0002) or protruding or pendulous papilla, Type 3 (36%; 95% CI, 29%-
43%; p=0,0075) was seen, compared with regular papilla, Type 1 (25%; 95% CI, 21%-
29%). No difference was found when comparing creased or ridged papilla, Type 4 (32%; 
95% CI, 21%-45%; p=0.22) with Type 1.  
The median time to successful bile duct cannulation was significantly longer for both 
Type 2 papilla (median time 269 seconds, IQR 622 seconds) and Type 3 papilla (median 
time 245 seconds, IQR 794 seconds, both p<0.05) compared with Type 1 papilla (median 
time 139 seconds, IQR 455 seconds). Cannulation time for creased or ridged papilla Type 
4 (median 210 seconds, IQR 515 seconds) was not significantly different from Type 1. 
In 99% of the ERCPs the endoscopists used guidewire-assisted cannulation. If 
cannulation became difficult, 50% of the endoscopists continued with guidewire 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
cannulation until cannulation succeeded or failed. In the remaining patients, different 
auxiliary cannulation techniques were used. Standard pre-cut technique as the only 
auxiliary method was used in 9%, pancreatic sphincterotomy in 15%, double-wire 
technique in 15% and combination of several techniques in 10%. No significant 
differences between the papilla types regarding choice of auxiliary technique was found.  
The overall post ERCP pancreatitis (PEP) frequency regardless of papilla type was 6.7% 
(95% CI, 5.5%-8.2%). When there was difficult cannulation the frequency of PEP 
increased to 8.9% compared with 5.1% (p=0.006) when cannulation was not difficult. 
There was also a variation in the frequency of PEP between the different papilla types but 
none of the differences were statistically significant. Regular, Type 1 papilla had a PEP 
frequency of 6.1% (95% CI, 4.6%-8.0%) whereas small, Type 2 papilla had 9.4% (95% 
CI, 5.9%-14.6%), protruding or pendulous, Type 3 papilla 6.4% (95% CI, 4.1%-9.7%) 
and creased or ridged, Type 4 had 7.5% (95% CI, 3.6%-14.3%). There was overall a low 
frequency of other adverse events such as postinterventional bleeding (0.2%) and 
cholangitis (0.6%) and there were no significant differences between the papilla types. 
The overall frequency of failed cannulation was low (2.8%; 95% CI, 2.1%-3.9%), with 
only nonsignificant differences between the different papilla types. However, the 
frequency of failed cannulation regardless of papilla type increased from 1.9% to 6.3% 
(p<0.0001) if a fellow started cannulation attempts compared with an expert, even though 
they had to turn the endoscope over to a more senior colleague after 5 minutes. This was 
especially pronounced for small, Type 2 papilla with an overall 14% failed cannulation 
frequency when a fellow started compared with 2.7% (p=0,018) when an expert 
performed the cannulation single-handedly. The OR, regardless of papilla type, for failed 
cannulation when a fellow started to cannulate compared with when an expert 
endoscopist started was 4.0 (95% CI, 2.0-8.2; p=0.0001). When a fellow started the OR 
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for failed cannulation on a small papilla was 6.1 (95% CI, 1.4-27; p=0.017) and on a 
protruding or pendulous papilla 5.2 (95% CI, 1.3-21; p=0.022) compared with when an 
expert started. 
 
Discussion 
Although many endoscopists have been assuming that the appearance of the major 
duodenal papilla has implications on bile duct cannulation no prospective investigation of 
this matter has previously been performed. By using our classification of the endoscopic 
appearance of the major duodenal papilla combined with the ESGE approved definition 
of difficult cannulation, we have determined that small, Type 2 papillae and protruding or 
pendulous, Type 3 papillae are more frequently difficult to cannulate. Accordingly, they 
also have a higher OR for difficult cannulation compared to regular, Type 1 papillae. 
These findings have previously only been assumed, based on expert opinion, and not on a 
validated classification of different papilla types and a prospective data collection4,11,12. 
With these results in mind, further research regarding cannulation difficulties has to take 
these aspects into consideration.  
In addition, this study demonstrates clear differences regarding frequency of difficult 
cannulation, between a fellow starting cannulation of a certain type of papilla, compared 
with when an expert is starting. This finding is, of course, obvious, but has previously not 
been quantified using the present definition for difficult cannulation or in regard to 
differences in endoscopic appearance of the papilla types. The differences in frequency of 
difficult cannulation might also be of use when evaluating competence among different 
endoscopists and during ERCP training. With beginners having a high ratio of difficult 
cannulation and experts a significantly lower ratio, and as difficult cannulation is a 
considerably more frequent phenomenon than failed cannulation and affects every 
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endoscopist to a varying degree, it can be used as an intraprocedural quality measure 
along with failed cannulation frequency20,21. Further studies regarding this might 
determine a benchmark for what frequency of difficult cannulation one should 
accomplish and maintain to be considered a qualified ERCP endoscopist. 
A more unexpected but intriguing and important finding is that when a fellow starts 
cannulation, the odds for failed cannulation increase significantly even as a more senior 
endoscopist continues cannulation attempts after 5 minutes. These findings also have 
implications on how education and training in ERCP and bile duct cannulation is 
conducted. For example, it may be suggested that when a fellow is confronted with a 
certain papilla type, i.e. small, Type 2 or protruding or pendulous, Type 3 papilla, they 
probably should abstain from any cannulation attempt and hand the endoscope over to a 
more experienced endoscopist from the very start, so as not to jeopardize further 
cannulation success. Perhaps during initial ERCP training focus should be shifted from 
bile duct cannulation attempts by the trainee, leaving that to the trainer, and instead 
focusing on other technical skills to complete a successful ERCP, not putting the patient 
at increased risk for failed cannulation. Simulator training, training on models or only 
starting procedures on patients who have previously been sphincterotomized is a safer 
path in the early phase of ERCP-learning22.  
In previous studies it was found that the factor “trainee participation” might have a slight 
negative influence on bile duct cannulation23,24. No definitive explanation for this finding 
was shown, but trauma to the papilla was discussed as a possible explanation. In contrast, 
other studies have not been able to identify this problem when evaluating trainees 
learning ERCP25,26. Frost et al27 made a structured effort to answer this question. 
However, in contrast to the present study they could not find any negative impact of 
letting a trainee start cannulation. None of these studies25–27 have, on the other hand, 
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considered the impact of the endoscopic appearance of the papilla on cannulation 
difficulties. The present study was not designed to investigate this unexpected finding, 
and consequently it needs to be evaluated in a more dedicated study to make any 
definitive statements regarding this finding. 
The same holds true for the post-ERCP pancreatitis (PEP) frequencies for the different 
papilla types. No significant differences between the papilla types regarding PEP 
frequency was seen in the present study, although there is a tendency that small papillae 
have a frequency of PEP in parallel with the increased frequency of difficult cannulation. 
In the present study, as well as in previous studies, there is a higher frequency of PEP if 
cannulation is difficult.28,29 The definition for difficult cannulation used is constructed 
with the risk of PEP as a decisive factor15. 
When a new classification is made, to be used in a clinical setting, one has to make some 
kind of compromise between usefulness and precision. Previously there have been 
suggestions for a classification of the endoscopic appearance of the papilla but it has not 
undergone any interobserver validation and been applied in studies concerning pre-cut 
cannulation technique9,30, not difficult cannulation per se. In the present study, we aimed 
at implementing a more universal, easy-to-use classification, in an everyday clinical 
setting to make the results more generalizable. As in all studies where different observers 
are called upon to make a judgement and determine what they believe is the correct 
classification, there will always be an uncertainty as to whether the “correct” decision is 
made. In contrast, one could ask oneself, how useful, in the clinical situation, is a 
classification if only dedicated experts can determine the “correct” answer? In the present 
and our previous study, we have tried to balance these opposing aspects to make a 
classification that is easy to use and understand, but still interobserver-validated to a 
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substantial degree, to both experts and beginners, making it relevant in everyday clinical 
practice.  
To summarize and conclude, the present study has shown that the endoscopic appearance 
of the major duodenal papilla affects bile duct cannulation. Small, Type 2 and protruding 
or pendulous Type 3 papillae are more often difficult to cannulate, especially for 
inexperienced endoscopists. Furthermore, the finding that when a fellow endoscopists 
start attempting bile duct cannulation the frequency of failed cannulation rises, even when 
a more experienced endoscopist continues cannulation, raises some concerns regarding 
endoscopy training.  
These findings have to be taken into consideration when performing studies regarding 
bile duct cannulation and in the training of future generations of endoscopists.  
 
Acknowledgements 
The study was supported by grants from the Research Fund at Skaraborg Hospital, Skövde, 
Sweden (VGSKAS 863391) and from the Stockholm County Council, the Karolinska   
Institutet (SLL: ALF 20170480)  
The authors wish to thank colleagues helpful with data aquisition: Per Bergenzaun, 
Roberto Valente, Alexander Waldthaler, Niklas Fagerström, Karolinska University 
Hospital, Stockholm Sweden. Tomas Manke, Anders Kylebäck och Åsa Fredriksson, 
Skaraborg Hospital, Skövde, Sweden. Marianne Udd, Mia Rainio, Andrea Tenca, 
Helsinki University Hospital, Helsinki, Finland. Sara Regnér, Gabriele Wurm Johanson, 
Artur Nemeth, Mats Hall, Skåne University Hospital, Malmö, Sweden.  
The authors also like to thank Fredrik Swahn, Skåne University Hospital, Lund, Sweden 
and Per Ejstrud, Aalborg University Hospital, Denmark for valuable intellectual input. 
 
References 
 
1. Adler DG. Guidewire cannulation in ERCP: from zero to hero! Gastrointest Endosc 
2018;87:202–4.  
 
2. Hawes RH, Devière J. How I cannulate the bile duct. Gastrointest Endosc 2018;87:1–3.  
 
3. Reddy ND, Nabi Z, Lakhtakia S. How to improve cannulation rates during endoscopic 
retrograde cholangiopancreatography. Gastroenterology 2017;152:1275–9.  
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 
4. Lee T, Hwang S, Choi H, et al. Sequential algorithm analysis to facilitate selective biliary 
access for difficult biliary cannulation in ERCP: a prospective clinical study. BMC 
Gastroenterol 2014;14:30.  
 
5. Lopes L., Dinis-Ribeiro M., Rolanda C. Early precut fistulotomy for biliary access: time to 
change the paradigm of “the later, the better”? Gastrointest Endosc 2014;80:634–41.  
 
6. Löhr J-M, Aabakken L, Arnelo U, et al. How to cannulate? A survey of the Scandinavian 
Association for Digestive Endoscopy (SADE) in 141 endoscopists. Scand J Gastroentero 
2012;47:861–9.  
 
7. Silvis SE., Vennes JA., Dreyer M. Variations in the normal duodenal papilla. Gastrointest 
Endosc 1983;29:132–3.  
 
8. Swan MP., Bourke MJ., Williams SJ., et al. Failed biliary cannulation: Clinical and 
technical outcomes after tertiary referral endoscopic retrograde cholangiopancreatography. 
World J Gastroentero 2011;17:4993–8.  
 
9. Horiuchi A., Nakayama Y., Kajiyama M., et al. Effect of Precut Sphincterotomy on Biliary 
Cannulation Based on the Characteristics of the Major Duodenal Papilla. Clin Gastroenterol 
H 2007;5:1113–8.  
 
10. Mariani A., Leo M., Giardullo N., et al. Early precut sphincterotomy for difficult biliary 
access to reduce post-ERCP pancreatitis: a randomized trial. Endoscopy 2016;48:530–5.   
 
11. Testoni P. No treatment for asymptomatic common bile ducts stones? Endosc Int Open 
2017;05:E1151–2.  
 
12. Matsushita M., Uchida K., Nishio A., et al. Small papilla: another risk factor for post-
sphincterotomy perforation. Endoscopy 2008;40:875–6.  
 
13. Liao W-C., Angsuwatcharakon P., Isayama H., et al. International consensus 
recommendations for difficult biliary access. Gastrointest Endosc 2017;85:295–304. 
 
14. Testoni P., Mariani A., Aabakken L., et al. Papillary cannulation and sphincterotomy 
techniques at ERCP: European Society of Gastrointestinal Endoscopy (ESGE) Clinical 
Guideline. Endoscopy 2016;48:657–83.  
 
15. Halttunen J., Meisner S., Aabakken L., et al. Difficult cannulation as defined by a 
prospective study of the Scandinavian Association for Digestive Endoscopy (SADE) in 907 
ERCPs. Scand J Gastroentero 2014;49:752–8.  
 
16. Haraldsson E., Lundell L., Swahn F., et al. Endoscopic classification of the papilla of 
Vater. Results of an inter- and intraobserver agreement study. United Eur Gastroent 
2016;5:504–10.  
 
17. Cotton P., Lehman G., Vennes J., et al. Endoscopic sphincterotomy complications and 
their management: an attempt at consensus. Gastrointestinal Endoscopy 1991;37:383–93.  
 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
18. Jowell P., Baillie J., Branch., et al. Quantitative assessment of procedural competence: a 
prospective study of training in endoscopic retrograde cholangiopancreatography. Ann Intern 
Med 1996;125:983-89.  
 
19. Yeo CJ., Sohn TA., Cameron JL., et al. Periampullary adenocarcinoma. Ann Surg 
1998;227:821–31.   
 
20. Adler DG., Lieb JG., Cohen J., et al. Quality indicators for ERCP. Gastrointest Endosc 
2015;81:54–66.   
 
21. Domagk D., Oppong KW., Aabakken L., et al. Performance measures for endoscopic 
retrograde cholangiopancreatography and endoscopic ultrasound: a European Society of 
Gastrointestinal Endoscopy (ESGE) Quality Improvement Initiative. United Eur Gastroent 
2018;6:1448–60.  
 
22. Jovanovic I., Mönkemüller K. Quality in endoscopy training—the endoscopic retrograde 
cholangiopancreatography case. Ann Transl Medicine 2018;6:264.  
 
23. Williams E., Ogollah R., Thomas P., et al. What predicts failed cannulation and therapy at 
ERCP? Results of a large-scale multicenter analysis. Endoscopy 2012;44:674–83.  
 
24. Peng C., Nietert PJ., Cotton PB., et.al. Predicting native papilla biliary cannulation 
success using a multinational endoscopic retrograde cholangiopancreatography (ERCP) 
quality network. Bmc Gastroenterol 2013;13:147.  
 
25. Pan Y., Zhao L., Leung J., et al. Appropriate time for selective biliary cannulation by 
trainees during ERCP – a randomized trial. Endoscopy 2015;47:688–95.   
 
26. Cotton PB., Garrow DA., Gallagher J., et al. Risk factors for complications after ERCP: a 
multivariate analysis of 11,497 procedures over 12 years. Gastrointest Endosc 2009;70:80–8.  
 
27. Frost J., Kurup A., Shetty S., et al. Does the presence of a trainee compromise success of 
biliary cannulation at ERCP? Endosc Int Open 2017;5:E559–62.  
 
28. Dumonceau J-M., Andriulli A., Elmunzer JB., et al. Prophylaxis of post-ERCP 
pancreatitis: European Society of Gastrointestinal Endoscopy (ESGE) Guideline – Updated 
June 2014. Endoscopy 2014;46:799–815.  
 
29. Elmunzer JB. Reducing the risk of postendoscopic retrograde cholangiopancreatography 
pancreatitis. Digest Endosc 2017;29:749–57.  
 
30. Lee T., Bang B., Park S-H., Jeong S., Lee D., Kim S-J. Precut fistulotomy for difficult 
biliary cannulation: is it a risky preference in relation to the experience of an endoscopist? 
Digest Dis Sci 2011;56:1896–903.   
  
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
Tables 
 
Table 1. Patient characteristics 
  
No of patients (n) 1401 
Female 52%  
Age, years, mean (SD) 66 (16) 
  
Indication for ERCP  
  Common bile duct stones 44% 
  Periampullary tumor 15% 
  Jaundice 13% 
  Stricture 9% 
  Primary sclerosing cholangitis 7% 
  Bile Leak 4% 
  Other 8% 
 
 
Table 2. Frequency of difficult cannulation, depending on experience and papilla type 
                 Experience   
 
Papilla type 
Expert Intermediate Fellow 
Type 1, regular papilla  25% 45%* 66%* 
Type 2, small papilla  43% 49%⊕ 83%* 
Type 3, protruding or pendulous papilla  36% 63%* 69%* 
Type 4, creased or ridged papilla 32% 44%⊕ 73%* 
Overall 30% 49%*  69%* 
*Significant difference (p<0.05) compared with Expert, ⊕ nonsignificant compared with Expert 
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Figure legends 
 
Figure 1. Classification of the endoscopic appearance of the papilla of Vater. 
Type 1 “Regular papilla”- Most common type with no distinctive features “classic 
appearance.” Type 2 “Small papilla”- Small, often flat with a diameter not bigger than 3 
mm (approx. 2 sphincterotome diam). Type 3 “Protruding or pendulous papilla”- A 
papilla that is protruding or bulging into the duodenal lumen sometimes hanging down, 
pendulous with the orifice oriented caudally. Type 4 “Creased or ridged papilla”- The 
ductal mucosa seems to extend distally out of the orifice either on a ridge or in a crease. 
 
 
Figure 2. Distribution of the different papilla types 
 
Figure 3. Frequency of difficult cannulation distributed among the different papilla 
types (95%CI) 
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Acronyms and abbrieviations 
 
ERCP=Endoscopic retrograde cholangiopancreatography 
95% CI = 95% confidence interval 
SADE= Scandinavian Association of Digestive Endoscopy 
ESGE= European Association of Gastrointestinal Endoscopy 
NSAIDs= Non-steroid anti-inflammatory Drugs 
PEP= Post-ERCP pancreatitis 
OR= Odds Ratio 
IQR = Inter quartile range 
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